Yuma Shibutani
Kashiwa, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Prescription Inquiries From Community Pharmacies Regarding Outpatient Opioid Prescriptions: A Retrospective Analysis of Content and Clinical Significance.
Journal: Journal of palliative medicine
Published: July 02, 2026
Details of oral anticancer drug prescription audits by community pharmacists: a retrospective analysis of prescription inquiries.
Journal: Journal of pharmaceutical health care and sciences
Published: February 28, 2026
Clinical Characteristics and Outcomes of Heart Failure with Preserved Ejection Fraction Versus Reduced Ejection Fraction in Patients Receiving Anticancer Drugs.
Journal: Cardiovascular toxicology
Published: October 30, 2025
Impact of vascular endothelial growth factor inhibitor-induced hypertension on continued cancer treatment: a systematic review and meta-analysis.
Journal: Hypertension research : official journal of the Japanese Society of Hypertension
Published: July 07, 2025
Asymptomatic Troponin Elevation and Early Mortality Following Immune Checkpoint Inhibitor Therapy in Patients Without Cardiac Adverse Events.
Journal: Cancer diagnosis & prognosis
Published: June 23, 2025
Questionnaire survey on efforts and challenges in cardio-oncology among pharmacists: A cross-sectional survey of the pharmacists of the Japanese Onco-Cardiology Society.
Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: June 11, 2025
A Fatal Case of Immune Checkpoint Inhibitor-Associated Myocarditis with Severe Right Ventricular Failure.
Journal: International heart journal
Published: May 14, 2025
Association between increased proteinuria induced by Bevacizumab, Ramucirumab, and Aflibercept and the risk of renal impairment and failure: a systematic review and meta-analysis.
Journal: International journal of clinical oncology
Published: March 19, 2025
Trends in renal function following vascular endothelial growth factor inhibitor administration in patients with cancer and diabetes mellitus.
Journal: Cancer chemotherapy and pharmacology
Published: March 01, 2025
Last Updated: 09/26/2026